Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18056999rdf:typepubmed:Citationlld:pubmed
pubmed-article:18056999lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0007587lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0002202lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C1564779lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C1517676lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:18056999lifeskim:mentionsumls-concept:C1527118lld:lifeskim
pubmed-article:18056999pubmed:issue9lld:pubmed
pubmed-article:18056999pubmed:dateCreated2008-2-25lld:pubmed
pubmed-article:18056999pubmed:abstractTextalphaA-crystallin (Cryaa/HSPB4) is a small heat shock protein and molecular chaperone that prevents nonspecific aggregation of denaturing proteins. Several point mutations in the alphaA-crystallin gene cause congenital human cataracts by unknown mechanisms. We took a novel approach to investigate the molecular mechanism of cataract formation in vivo by creating gene knock-in mice expressing the arginine 49 to cysteine mutation (R49C) in alphaA-crystallin (alphaA-R49C). This mutation has been linked with autosomal dominant hereditary cataracts in a four-generation Caucasian family. Homologous recombination in embryonic stem cells was performed using a plasmid containing the C to T transition in exon 1 of the cryaa gene. alphaA-R49C heterozygosity led to early cataracts characterized by nuclear opacities. Unexpectedly, alphaA-R49C homozygosity led to small eye phenotype and severe cataracts at birth. Wild type littermates did not show these abnormalities. Lens fiber cells of alphaA-R49C homozygous mice displayed an increase in cell death by apoptosis mediated by a 5-fold decrease in phosphorylated Bad, an anti-apoptotic protein, but an increase in Bcl-2 expression. However, proliferation measured by in vivo bromodeoxyuridine labeling did not decline. The alphaA-R49C heterozygous and homozygous knock-in lenses demonstrated an increase in insoluble alphaA-crystallin and alphaB-crystallin and a surprising increase in expression of cytoplasmic gamma-crystallin, whereas no changes in beta-crystallin were observed. Co-immunoprecipitation analysis showed increased interaction between alphaA-crystallin and lens substrate proteins in the heterozygous knock-in lenses. To our knowledge this is the first knock-in mouse model for a crystallin mutation causing hereditary human cataract and establishes that alphaA-R49C promotes protein insolubility and cell death in vivo.lld:pubmed
pubmed-article:18056999pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:languageenglld:pubmed
pubmed-article:18056999pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:citationSubsetIMlld:pubmed
pubmed-article:18056999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18056999pubmed:statusMEDLINElld:pubmed
pubmed-article:18056999pubmed:monthFeblld:pubmed
pubmed-article:18056999pubmed:issn0021-9258lld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:FeitH LHLlld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:AndleyUsha...lld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:MenkoA SueASlld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:GrossJuliaJlld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:TownsendR...lld:pubmed
pubmed-article:18056999pubmed:authorpubmed-author:XiJing-huaJHlld:pubmed
pubmed-article:18056999pubmed:issnTypePrintlld:pubmed
pubmed-article:18056999pubmed:day29lld:pubmed
pubmed-article:18056999pubmed:volume283lld:pubmed
pubmed-article:18056999pubmed:ownerNLMlld:pubmed
pubmed-article:18056999pubmed:authorsCompleteYlld:pubmed
pubmed-article:18056999pubmed:pagination5801-14lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:meshHeadingpubmed-meshheading:18056999...lld:pubmed
pubmed-article:18056999pubmed:year2008lld:pubmed
pubmed-article:18056999pubmed:articleTitleMechanism of small heat shock protein function in vivo: a knock-in mouse model demonstrates that the R49C mutation in alpha A-crystallin enhances protein insolubility and cell death.lld:pubmed
pubmed-article:18056999pubmed:affiliationDepartment of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA.lld:pubmed
pubmed-article:18056999pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18056999pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:1409entrezgene:pubmedpubmed-article:18056999lld:entrezgene
entrez-gene:12954entrezgene:pubmedpubmed-article:18056999lld:entrezgene
entrez-gene:12955entrezgene:pubmedpubmed-article:18056999lld:entrezgene
entrez-gene:17339entrezgene:pubmedpubmed-article:18056999lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18056999lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18056999lld:pubmed